Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

In vivo data support clinical development of VX15/2503 for MS

Oct. 25, 2010

Scientists identify potential biomarkers of delirium in ICU patients

Oct. 22, 2010

DHOdehase inhibitor LAS-186323 shows favorable safety and pharmacokinetics

Oct. 22, 2010

Continued benefit seen with 4-year odanacatib therapy in postmenopausal women

Oct. 22, 2010

Phase II trials assess Amgen's antibodies in pancreatic and non-small cell lung cancer

Oct. 22, 2010

Oncolytic vaccinia virus GL-ONC1 well tolerated in patients with solid cancers

Oct. 22, 2010

Phase I trial evaluates MVA-BN PRO in castration-resistant prostate cancer

Oct. 21, 2010

ONO-4641 shows safety and tolerability in phase I trial in MS

Oct. 21, 2010

Subanalyses of CLARITY data support benefits of cladribine tablets

Oct. 21, 2010

Zealand Pharma's ZP-2307 shows bone anabolic activity in vivo

Oct. 21, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026